Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population

Endocrine

Volumn 44, Issue 3, 2013, Pages 702-709

  Alkhateeb, Asem ^a   Marzouka, Nour Al Dain ^a,b   Tashtoush, Reema ^c  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b Montpellier University Medical Center   (France)

^c Ibn Alnafees Hospital   (Jordan)

Author keywords

Association; Polymorphism; PTPN22; SMOC2; Thyroid

Indexed keywords

ADENINE; GUANINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; AGED; ARAB; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHORESIS; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; JORDANIAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PTPN22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOC2 GENE; VERY ELDERLY; YOUNG ADULT;

ADULT; ALLELES; ARABS; AUTOIMMUNE DISEASES; CALCIUM-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HAPLOTYPES; HASHIMOTO DISEASE; HUMANS; JORDAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; VITILIGO;

EID: 84890792959     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9908-z     Document Type: Article

References (35)

1. D.L. Jacobson, S.J. Gange, N.R. Rose, N.M. Graham, Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223-243 (1997)
2. D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252-265 (2012)
3. T.F. Davies, R. Latif, X. Yin, New genetic insights from autoimmune thyroid disease. J. Thyroid. Res. 2012, 623852 (2012)
4. L.Q. Gu, W. Zhu, S.X. Zhao, L. Zhao, M.J. Zhang, B. Cui, H.D. Song, G. Ning, Y.J. Zhao, Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Clin. Endocrinol. (Oxf). 72, 248-255 (2010)
5. N. Eriksson, J.Y. Tung, A.K. Kiefer, D.A. Hinds, U. Francke, J.L. Mountain, C.B. Do, Novel associations for hypothyroidism include known autoimmune risk loci. PLoS ONE 7, e34442 (2012)
6. N. Inoue, M. Watanabe, H. Yamada, K. Takemura, F. Hayashi, N. Yamakawa, M. Akahane, Y. Shimizuishi, Y. Hidaka, Y. Iwatani, Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J. Clin. Immunol. (2012). doi: 10.1007/s10875-012-9721-0
7. L. Luo, B. Cai, F. Liu, X. Hu, L. Wang, Association of protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: a meta-analysis. Endocr. J. 59, 439-445 (2012)
8. D. Zhebrun, Y. Kudryashova, A. Babenko, A. Maslyansky, N. Kunitskaya, D. Popcova, A. Klushina, E. Grineva, A. Kostareva, E. Shlyakhto, Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. Aging (Albany NY). 3, 368-373 (2011)
9. G. Chabchoub, E.P. Teixiera, A. Maalej, M. Ben Hamad, Z. Bahloul, F. Cornelis, H. Ayadi, The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann. Hum. Biol. 36, 342-349 (2009)
10. G. Dultz, N. Matheis, M. Dittmar, B. Röhrig, K. Bender, G.J. Kahaly, The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid. 19, 143-148 (2009)
11. R.M. Plenge, L. Padyukov, E.F. Remmers, S. Purcell, A.T. Lee, E.W. Karlson, F. Wolfe, D.L. Kastner, L. Alfredsson, D. Altshuler, P.K. Gregersen, L. Klareskog, J.D. Rioux, Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4 and PADI4. Am. J. Hum. Genet. 77, 1044-1060 (2005)
12. A.B. Begovich, V.E. Carlton, L.A. Honigberg, S.J. Schrodi, A.P. Chokkalingam, H.C. Alexander, K.G. Ardlie, Q. Huang, A.M. Smith, J.M. Spoerke, M.T. Conn, M. Chang, S.Y. Chang, R.K. Saiki, J.J. Catanese, D.U. Leong, V.E. Garcia, L.B. McAllister, D.A. Jeffery, A.T. Lee, F. Batliwalla, E. Remmers, L.A. Criswell, M.F. Seldin, D.L. Kastner, C.I. Amos, J.J. Sninsky, P.K. Gregersen, A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330-337 (2004)
13. T. Vang, M. Congia, M.D. Macis, L. Musumeci, V. Orrú, P. Zavattari, K. Nika, L. Tautz, K. Taskén, F. Cucca, T. Mustelin, N. Bottini, Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37, 1317-1319 (2005)
14. H. Kahles, E. Ramos-Lopez, B. Lange, O. Zwermann, M. Reincke, K. Badenhoop, Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol. 153, 895-899 (2005)
15. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, Y. Ban, The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid. 15, 1115-1118 (2005)
16. J.M. Heward, O.J. Brand, J.C. Barrett, J.D. Carr-Smith, J.A. Franklyn, S.C. Gough, Association of PTPN22 haplotypes with Graves' disease. J. Clin. Endocrinol. Metab. 92, 685-690 (2007)
17. N.J. Cox, B. Wapelhorst, V.A. Morrison, L. Johnson, L. Pinchuk, R.S. Spielman, J.A. Todd, P. Concannon, Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am. J. Hum. Genet. 69, 820-830 (2001)
18. D. Owerbach, Physical and genetic mapping of IDDM8 on chromosome 6q27. Diabetes 49, 508-512 (2000)
19. J.L. Davies, F. Cucca, J.V. Goy, Z.A. Atta, M.E. Merriman, A. Wilson, A.H. Barnett, S.C. Bain, J.A. Todd, Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes. Hum. Mol. Genet. 5, 1071-1074 (1996)
20. D.F. Luo, M.M. Bui, A. Muir, Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am. J. Hum. Genet. 57, 911-919 (1995)
21. A. Myerscough, S. John, J.H. Barrett, W.E. Ollier, J. Worthington, Linkage of rheumatoid arthritis to insulin-dependent diabetes mellitus loci: evidence supporting a hypothesis for the existence of common autoimmune susceptibility loci. Arthr. Rheum. 43, 2771-2775 (2000)
22. S.A. Birlea, K. Gowan, P.R. Fain, R.A. Spritz, Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J. Invest. Dermatol. 130, 798-803 (2010)
23. E.F. Rocnik, P. Liu, K. Sato, K. Walsh, C. Vaziri, The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J. Biol. Chem. 32, 22855-22864 (2006)
24. P. Liu, D.E. Pazin, R.R. Merson, The developmentally regulated Smoc2 gene is repressed by aryl-hydrocarbon receptor (Ahr) signaling. Gene 15, 72-80 (2009)
25. A. Allahabadia, S.C. Gough, The different approaches to the genetic analysis of autoimmune thyroid disease. J. Endocrinol. 163, 7-13 (1999)
26. Y. Tomer, G. Barbesino, M. Keddache, D.A. Greenberg, T.F. Davies, Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J. Clin. Endocr. Metab. 82, 1645-1648 (1997)
27. T.G. Strieder, M.F. Prummel, Risk factors for and prevalence of thyroid disorders in a cross sectional study among healthy female relatives of patients with autoimmune thyroid disorder. Clin. Endocrinol. (OXF). 59, 396-401 (2003)
28. Z.H. Zhang, F. Chen, X.L. Zhang, Y. Jin, J. Bai, S.B. Fu, PTPN22 allele polymorphisms in 15 Chinese populations. Int. J. Immunogenet. 35, 433-437 (2008)
29. M. Pertovaara, A. Raitala, M. Juonala, M. Kähönen, T. Lehtimäki, J.S. Viikari, O.T. Raitakari, M. Hurme, Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis. The cardiovascular risk in Young Finns study. Clin. Exp. Immunol. 147, 265-269 (2007)
30. J.A. Lopez-Escamez, P. Saenz-Lopez, L. Acosta, A. Moreno, I. Gazquez, H. Perez-Garrigues, A. Lopez-Nevot, M.A. Lopez-Nevot, Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Meniere's disease. Laryngoscope. 120, 103-107 (2010)
31. M.C. Totaro, B. Tolusso, V. Napolioni, F. Faustini, S. Canestri, A. Mannocci, E. Gremese, S.L. Bosello, S. Alivernini, G. Ferraccioli, PTPN22 1858C > T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis. PLoS ONE 6, e24292 (2011)
32. N. Bottini, T. Vang, F. Cucca, T. Mustelin, Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18, 207-213 (2006)
33. Y. Ban, T. Tozaki, M. Taniyama, Y. Nakano, Y. Ban, Y. Ban, T. Hirano, Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid. 20, 893-899 (2010)
34. A. Alkhateeb, N. Al-Dain Marzouka, A. Qarqaz, SMOC2 gene variant and the risk of vitiligo in Jordanian Arabs. Eur. J. Dermatol. 20, 701-704 (2010)
35. E. Toyoshi, K. Tetsuro, Immunization with thyroglobulin induces Graves'-like disease in mice. J. Endocrinol. 202, 217-222 (2009)